155A.32 - DRUG PRODUCT SELECTION -- RESTRICTIONS.
155A.32 DRUG PRODUCT SELECTION -- RESTRICTIONS.
1. If an authorized prescriber prescribes, in writing,
electronically, by facsimile, or orally, a drug by its brand or trade
name, the pharmacist may exercise professional judgment in the
economic interest of the patient by selecting a drug product with the
same generic name and demonstrated bioavailability as the one
prescribed for dispensing and sale to the patient. If the cost of
the prescription or any part of it will be paid by expenditure of
public funds authorized under chapter 249A, the pharmacist shall
exercise professional judgment by selecting a drug product with the
same generic name and demonstrated bioavailability as the one
prescribed for dispensing and sale. If the pharmacist exercises drug
product selection, the pharmacist shall inform the patient of the
savings which the patient will obtain as a result of the drug product
selection and pass on to the patient no less than fifty percent of
the difference in actual acquisition costs between the drug
prescribed and the drug substituted.
2. The pharmacist shall not exercise the drug product selection
described in this section if either of the following is true:
a. The prescriber specifically indicates that no drug product
selection shall be made.
b. The person presenting the prescription indicates that only
the specific drug product prescribed should be dispensed. However,
this paragraph does not apply if the cost of the prescription or any
part of it will be paid by expenditure of public funds authorized
under chapter 249A.
3. If selection of a generically equivalent product is made under
this section, the pharmacist making the selection shall note that
fact and the name of the manufacturer of the selected drug on the
prescription presented by the patient or the patient's adult
representative or transmitted by the prescriber or the prescriber's
authorized agent. Section History: Recent Form
87 Acts, ch 215, § 32; 2004 Acts, ch 1036, §17